Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who need coronary bypass heart surgery (surgery to improve blood flow to the heart)
- People having the surgery either as a planned procedure or as a medical emergency
- People who have not had any previous heart surgery
- People whose heart is pumping at a certain minimum level of strength (known as an ejection fraction of 30% or above)
- People who are enrolled in a social security or health insurance system
- People who have signed a consent form agreeing to take part
- People who have stopped taking certain blood pressure medications (renin-angiotensin system inhibitors, angiotensin-neprilysin receptor blockers, and sartans) the day before the surgery
Who may not be able to join:
- People for whom a certain type of medication used to support heart function (called an inotropic substance) is not safe to use
- People for whom a technique called passive leg raising (gently lifting the legs to shift blood flow) is not appropriate
- People in an immediately life-threatening emergency situation
- People who have had heart surgery before
- People who have a complete blockage in certain major arteries in the hips or upper legs (bilateral iliac or common femoral artery occlusion)
- People whose heart pumping strength is below a certain level (ejection fraction below 30%)
- People who are pregnant or breastfeeding
- People with significant kidney problems (a kidney filtration rate below 40 ml/min/1.73 m²)
- People who have had both legs amputated above the knee
- People with a very high body weight classified as Class III obesity (BMI above 40 kg/m²)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 426297927
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess use of noradrenaline in the experimental group (postural mobilization) vs control group (NA only) for hemodynamic management during open-heart coronary bypass graft surgery.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.